Human papillomavirus testing with a liquid-based system: Feasibility and comparison with reference diagnoses

Acta Cytologica

Volumn 50, Issue 1, 2006, Pages 16-22

  Bergeron, Christine ^a   Cas, Frederic ^a   Fagnani, Francis ^b   Didailler Lambert, Frederic ^a   Poveda, Jean Dominique ^a  

^a LABORATOIRE CERBA   (France)

^b Conseil en Economie Medicale/KA ^*  (France)

Author keywords

Cervical cancer; Cervix diseases; Human papillomavirus; Liquid based cytology

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; DIAGNOSTIC KIT; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID BASED CYTOLOGY; MAJOR CLINICAL STUDY; NONHUMAN; ONCOVIRINAE; PRIORITY JOURNAL; SCREENING TEST; STATISTICAL ANALYSIS; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; ONCOVIRINAE;

EID: 31544460999     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000325889     Document Type: Article

References (20)

1. Abulafia O, Pezzullo JC, Sherer DM: Performance of Thin-Prep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: A qualitative survey. Gynecol Oncol 2003;90:137-144
2. Agence Nationale d'Accréditation et d'Evaluation en Santé: Recommandations pour la pratique clinique: Conduite à tenir devant une patiente ayant un frottis cervico-utérin anormal, actualisation 2002 (www.anaes.fr)
3. Arbyn M, Buntinx F, van Ranst M, Paraskevaidis E, Martin-Hirsh P, Dillner J: Virologic versus cytologic triage of women with equivocal pap smears: A meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 2004;96:280-293
4. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study Group: Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: Baseline data from a randomized trial. J Natl Cancer Inst 2000;92:397-402
5. Bergeron C, Fagnani F: Performance of a new, liquid-based cervical screening technique in the clinical setting of a large French laboratory. Acta Cytol 2003;47:453-761
6. Bergeron C, Jeannel D, Poveda JD, Cassonnet P, Orth G: Human papillomavirus testing in women with mild cytologic atypia. Obstet Gynecol 2000;95:821-827
7. Bernstein SJ, Sanchez-Ramos L, Ndubisi B: Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: A meta-analysis of prospective studies comparing cytologic diagnosis and sample adequacy. Am J Obstet Gynecol 2001;185:308-317
8. Castle PE, Solomon D, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Rodriguez AC, Alfaro M, Hutchinson ML, Dunn ST, Kuypers J, Schiffman M: Stability of archived liquid-based cervical cytologic specimens. Cancer Cytopathol 2003; 99:89-96
9. Goldie SJ, Kim JJ, Wright TC: Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more. Obstet Gynecol 2004;103:619-631
10. Guidance on the use of liquid-based cytology for cervical screening. Commissioned by Health Technology Assessment Programme on behalf of the National Institute for Clinical Excellence, 2003 (www.nice.org.uk)
11. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD: A natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-428
12. Hutchinson ML, Zahniser DJ, Sherman ME, Herrero R, Alfaro M, Bratti MC, Hildesheim A, Lorincz AT, Greenberg MD, Morales J, Schiffman M: Utility of liquid-based cytology for cervical carcinoma screening: Results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma. Cancer 1999;87:48-55
13. Hybrid Capture II, package insert, 2003
14. Kim JJ, Wright TC, Goldie SJ: Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002;287:2382-2390
15. Negri G, Rigo B, Vittadello F, Egarter-Vigl E, Mian C: Human papillomavirus typing with hybrid capture II on archived liquid-based cytologic specimens. Am J Clin Pathol 2004;122:90-93
16. Sherman ME, Schiffman MH, Lorincz A, Herrero R, Hutchinson ML, Bratti C, Zahniser D, Morales J, Hildesheim A, Helgesen K, Kelly D, Alfaro M, Mena F, Balmaceda I, Mango L, Greenberg M: Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing. Cancer (Cancer Cytopathol) 1997;81:89-97
17. Solomon D, Schiffman M, Tarrone R: Comparison of three management strategies for patients with atypical squamous cells of undetermined significance. J Natl Cancer Inst 2001;93:293-299
18. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Young N: The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119
19. Vassilakos P, Petignat P, Boulvain M, Campana A: Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing. Br J Cancer 2002;86:382-388
20. Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ: 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-2129